Company Cest Pharma S.r.l. with Fiscal Code 30042555
recorded a turnover of 2024 of
199.993,
with a net profit of
120.576
and having an average number of employees of
1.
The company operates in the field of Leasing cu bunuri intangibile (cu excepția lucrărilor care fac obiectul drepturilor de autor) having the NACE code 7740.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Cest Pharma S.r.l.
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
0
0
-
0
77.447
64.585
43.050
422.447
211.173
199.993
Total Income - EUR
0
0
-
0
81.557
65.661
43.054
429.098
211.237
200.028
Total Expenses - EUR
0
0
-
0
74.154
63.082
34.144
260.002
123.404
74.310
Gross Profit/Loss - EUR
0
0
-
0
7.403
2.579
8.910
169.095
87.833
125.718
Net Profit/Loss - EUR
0
0
-
0
5.955
1.914
8.514
164.890
85.720
120.576
Employees
0
0
-
0
1
1
1
1
1
1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales decreased by -4.8%, from 211.173 euro in the year 2023, to 199.993 euro in 2024.
The Net Profit increased by 35.335 euro, from 85.720 euro in 2023, to 120.576 in the last year.
Check the financial reports for the company - Cest Pharma S.r.l.
Financial Rating - CEST PHARMA S.R.L.
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Cest Pharma S.r.l.
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Cest Pharma S.r.l.
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Cest Pharma S.r.l.
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Cest Pharma S.r.l. - CUI 30042555
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Fixed Assets
0
0
-
0
0
0
0
1.244
58.787
45.601
Current Assets
44.310
43.859
-
42.325
38.332
42.784
57.510
186.183
113.124
147.343
Inventories
18.613
18.423
-
17.779
26.038
19.140
31.381
15.227
0
0
Receivables
25.662
25.400
-
24.512
11.599
21.924
23.490
142.874
61.266
147.254
Cash
36
36
-
34
695
1.720
2.639
28.081
51.857
89
Shareholders Funds
23.580
23.340
-
22.524
27.631
29.021
36.891
180.468
101.251
120.624
Social Capital
45
45
-
43
42
41
40
41
40
40
Debts
20.730
20.519
-
19.801
10.702
13.763
20.618
6.958
70.660
72.774
Income in Advance
0
0
-
0
0
0
0
0
0
0
Exchange rate - RON
4.9743
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
Main CAEN
"7740 - 7740"
CAEN Financial Year
7740
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
147.343 euro in 2024 which includes Inventories of
0 euro, Receivables of
147.254 euro and cash availability of
89 euro.
The company's Equity was valued at
120.624 euro, while total Liabilities amounted to
72.774 euro.
Equity increased by 19.939 euro, from 101.251 euro in 2023, to 120.624 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Cest Pharma S.r.l.